Cargando…
Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809614/ https://www.ncbi.nlm.nih.gov/pubmed/27019424 http://dx.doi.org/10.1371/journal.pone.0152845 |
| _version_ | 1782423670200729600 |
|---|---|
| author | Nagata, Eiichiro Ogino, Mieko Iwamoto, Kounosuke Kitagawa, Yasuhisa Iwasaki, Yasuo Yoshii, Fumihito Ikeda, Joh-E. |
| author_facet | Nagata, Eiichiro Ogino, Mieko Iwamoto, Kounosuke Kitagawa, Yasuhisa Iwasaki, Yasuo Yoshii, Fumihito Ikeda, Joh-E. |
| author_sort | Nagata, Eiichiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4809614 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48096142016-04-05 Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients Nagata, Eiichiro Ogino, Mieko Iwamoto, Kounosuke Kitagawa, Yasuhisa Iwasaki, Yasuo Yoshii, Fumihito Ikeda, Joh-E. PLoS One Correction Public Library of Science 2016-03-28 /pmc/articles/PMC4809614/ /pubmed/27019424 http://dx.doi.org/10.1371/journal.pone.0152845 Text en © 2016 Nagata et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Nagata, Eiichiro Ogino, Mieko Iwamoto, Kounosuke Kitagawa, Yasuhisa Iwasaki, Yasuo Yoshii, Fumihito Ikeda, Joh-E. Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients |
| title | Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients |
| title_full | Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients |
| title_fullStr | Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients |
| title_full_unstemmed | Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients |
| title_short | Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients |
| title_sort | correction: bromocriptine mesylate attenuates amyotrophic lateral sclerosis: a phase 2a, randomized, double-blind, placebo-controlled research in japanese patients |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809614/ https://www.ncbi.nlm.nih.gov/pubmed/27019424 http://dx.doi.org/10.1371/journal.pone.0152845 |
| work_keys_str_mv | AT nagataeiichiro correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients AT oginomieko correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients AT iwamotokounosuke correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients AT kitagawayasuhisa correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients AT iwasakiyasuo correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients AT yoshiifumihito correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients AT ikedajohe correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients AT correctionbromocriptinemesylateattenuatesamyotrophiclateralsclerosisaphase2arandomizeddoubleblindplacebocontrolledresearchinjapanesepatients |